.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Dr. Rolf Kaiser

Cologne / DE

University Hospital of Cologne

Vorsitz

25.03.2024
15:45 – 17:15
Workshop
Antiviral therapy and resistance 1
Lecture hall 3
28.03.2024
11:00 – 12:30
Workshop
Antiviral therapy and resistance 2
Lecture hall 3

Vortrag

25.03.2024
Poster
P 193
CMV in transplant recipients – Identifying patients at high risk for complicated-to-treat CMV infections and combined therapy approach
Virus infections and the immunocompromised host

Weitere Beteiligungen

25.03.2024
Poster
P 482
Interplay between HIV and Human Pegivirus (HPgV) Load in Co-Infected Patients: Insights from prevalence and genotype analysis
Virus pathogenesis and persistance
25.03.2024
Poster
P 193
CMV in transplant recipients – Identifying patients at high risk for complicated-to-treat CMV infections and combined therapy approach
Virus infections and the immunocompromised host
25.03.2024
Poster
P 188
Torque teno virus load is associated with CDC stage and CD4+ cell count in people living with HIV but unrelated to AIDS-defining events and human pegivirus load
Virus infections and the immunocompromised host
25.03.2024
Poster
P 101
Geno2pheno: De Novo Recombination detection of A6 subtypes
Antiviral therapy and resistance
25.03.2024
Poster
P 440
Follow-up: Respiratory viruses dynamics and interactions: ten years of surveillance in central Europe
Respiratory viruses
28.03.2024
12:00 – 12:15 12 Min. 3 Min.
Abstract talk
O 110
Geno2pheno-bNAbs: Interpretable and accurate prediction of HIV bNAb resistance
Antiviral therapy and resistance